Related Experiment Videos
[Conisation in stage Ia cervix cancer]
Geburtshilfe Und Frauenheilkunde
|July 1, 1994
Summary
Conisation effectively treats early-stage cervical cancer (Ia1 and Ia2). Thorough histological examination is crucial for determining appropriate treatment and ensuring complete tumor removal in cervical cancer patients.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Early-Stage Cervical Cancer
Context:
- Cervical cancer stage Ia requires precise management.
- Positive Pap smears necessitate further investigation.
- Conisation is a primary treatment modality for early cervical neoplasia.
Purpose:
- To evaluate the efficacy of conisation as a standalone therapy for cervical cancer stage Ia1 and Ia2.
- To emphasize the critical role of accurate histological examination in treatment planning and outcome assessment.
- To analyze recurrence and residual disease rates following conisation in early-stage cervical cancer.
Summary:
- A retrospective study analyzed 78 patients with cervical cancer stage Ia (Ia1 and Ia2) treated with conisation.
- Complete tumor removal was achieved in 51 patients; 23 had positive margins (carcinoma in situ or invasive carcinoma).
- Follow-up hysterectomy revealed residual disease in a subset of patients, particularly those with positive conisation margins, highlighting the importance of histological review.
Impact:
- Conisation can be a definitive treatment for select early-stage cervical cancers with favorable prognostic factors.
- Incomplete resection necessitates further surgical intervention.
- Accurate pathological assessment of conisation specimens is paramount for patient management and prognosis in cervical cancer.